• Connect with us
  • Information
    • About Us
    • Contact Us
    • Careers
    • Partnerships
    • Advertise With Us
    • Authors
    • Browse Topics
    • Events
    • Disclaimer
    • Privacy Policy
  • NORTH AMERICA EDITION
    Australia
    North America
    World
Login
Investing News NetworkYour trusted source for investing success
  • NORTH AMERICA EDITION
    North America
    Australia
    World
  • My INN
Videos
Companies
Press Releases
Private Placements
SUBSCRIBE
  • Reports & Guides
    • Market Outlook Reports
    • Investing Guides
  • Button
Resource
  • Precious Metals
  • Battery Metals
  • Base Metals
  • Energy
  • Critical Minerals
Tech
Life Science
Cannabis Market
Cannabis News
Cannabis Stocks
  • Cannabis Market
  • Cannabis News
  • Cannabis Stocks
cannabis investing

Valens Groworks Appoints President

Matthew Spizziri
Mar. 14, 2017 01:26PM PST
Cannabis Investing News

Mark Doucet has joined Valens GroWorks Corp. (CSE:VGW) as its president.

Mark Doucet has joined Valens GroWorks Corp. (CSE:VGW) as its president.
Mark Doucet has more than 25 years of senior executive experience. He has been involved in and advised on capital markets, infrastructure, commercial real estate, precious metals and other industries both foreign and domestic. Past service includes: President of a US junior exploration company, President of a business/government relations company, Founder and President of a wireless application company, and Vice President for several Canadian junior exploration companies, an international government/business consulting firm and an Atlantic Canada restaurant franchise. Mark served as Financial Officer and Development Planner for the privatization and redevelopment of Toronto’s Pearson International Airport. Mark and his wife have two boys, and reside in Ottawa.
Mark commented “Valens GroWorks Corp. has vastly superior products and people completely motivated to realize their vision of excellence by leading this quickly evolving industry. Drawing on this vision, I am passionately energized to help the Valens GroWorks team become an industry leader in this space.”
Robert van Santen, the Company’s CEO and Chair commented “I am particularly pleased that a seasoned and visionary leader like Mark has chosen our Company and its team as his vehicle to enter into this rapid-growth sector as the repeal of prohibition looms in Canada. The industry is in transition from the legacy world of commercial marijuana — legal, quasi-legal, gray market, illicit — to the future, which will see a fully institutionalized market.”
Read the full company profile.
Option Grant
The Company is granting stock options to acquire an aggregate of one million common shares in the capital of the Company at an exercise price of $1.40 per common share, expiring on the fifth anniversary of the grant (collectively, the “Stock Option”). The Stock Option vests in stages over the course of two (2) years with 12.5% to vest immediately and a further 12.5% to vest in each three-month period thereafter, and is exercisable quarterly after 12 months, with the balance after 24 months from the Commencement Date. The Stock Options are being granted in accordance with the Company’s stock option plan, and are subject to regulatory approval.
About Valens GroWorks Corp.
Valens GroWorks Corp is a Canadian Securities Exchange listed company with an aggressive acquisition strategy in progress, providing management, consulting, testing and support services to domestic and international licensees, as well as financing the buildout of established, fully-licensed operations pursuant to its investment in Arizona. The Company seeks to capture a broad spectrum of medical marijuana users, as well as recreational users once legalized, in pursuit of its ambitious seed to sale and farm to pharma objectives.
The Company’s wholly-owned subsidiary, Valens Agritech Ltd. (“VAL”), is a post-inspection applicant awaiting the granting of a Controlled Drugs and Substances Dealer’s Licence for the cultivation and processing of marijuana. Based in the Okanagan Valley of British Columbia, VAL anticipates participation in selective clinical trial programs researching the efficacy of medical cannabis.
The Company is about to close the signed Share Exchange Agreement (SEA) with Supra THC Services Inc. (“Supra”) which will become a wholly-owned subsidiary. Supra holds a Health Canada Dealer’s Licence and is providing sector-leading analytical services for Licensed Producers and ACMPR patients.
Connect with Valens GroWorks Corp. (CSE:VGW) to receive an Investor Presentation.

cannabis investing valens agritech canada
The Conversation (0)

Go Deeper

AI Powered
License Advantage: Canada’s B2B Wholesale Cannabis Marketplace

License Advantage: Canada’s B2B Wholesale Cannabis Marketplace

The Valens Company

The Valens Company

Latest News

Outlook Reports

Resource
  • Precious Metals
    • Gold
    • Silver
  • Battery Metals
    • Lithium
    • Cobalt
    • Graphite
    • Electric Vehicles
  • Agriculture
  • Base Metals
    • Copper
    • Nickel
    • Zinc
  • Critical Metals
    • Rare Earths
  • Energy
    • Uranium
    • Oil and Gas
Tech
    • Artificial Intelligence
    • Cybersecurity
    • Robotics
    • Crypto
    • Cleantech
Life Science
    • Biotech
    • Cannabis
    • Pharmaceuticals

Featured Cannabis Investing News Stocks

extractX

extractX (None)
More featured stocks

Browse Companies

Resource
  • Precious Metals
  • Battery Metals
  • Energy
  • Base Metals
  • Critical Metals
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES